Post by Alamar Biosciences, Inc.

Name: What’s driving conversations at #AAIC2026? In this conference highlight, Alamar CSO Steve Williams
Uploaded: 2026-07-14T17:01:02.454Z
Channel: Alamar Biosciences, Inc.
Description: What’s driving conversations at #AAIC2026? In this conference highlight, Alamar CSO Steve Williams shares three key observations from the meeting: 🔬 The growing momentum behind new Alzheimer's ther

30,879 followers

What’s driving conversations at #AAIC2026? In this conference highlight, Alamar CSO Steve Williams shares three key observations from the meeting: 🔬 The growing momentum behind new Alzheimer's therapies and the need for tools to evaluate their impact. 🧠 Recognition that no single biomarker can tell the whole story, driving a shift toward multiplex approaches that capture disease complexity and heterogeneity. 🩸 Increasing demand for scalable, blood-based biomarkers to support patient selection, disease staging, and treatment monitoring in clinical trials. Watch the video to hear Steve's perspective on how precision proteomics and multiplex biomarker profiling are helping shape the future of Alzheimer's research and clinical development. Come visit Alamar at Booth 530 to continue the conversations. #AAIC2026 #AlzheimersResearch #Biomarkers #PrecisionProteomics #ClinicalTrials #Neurodegeneration #NULISA

Video Content